Molecular targeted therapy for advanced gastric cancer
Although medical treatment has been shown to improve quality of life and prolong survival, no significant progress has been made in the treatment of advanced gastric cancer (AGC) within the last two decades. Thus, the optimum standard first-line chemotherapy regimen for AGC remains debatable, and mo...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
The Korean Association of Internal Medicine
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604602/ |